A challenge associated with the use of stent-based MIGS is that the location of increased aqueous outflow resistance is often unclear – when targeting a small area of the outflow system with stent-based MIGS there is a risk that the area of blockage will be missed or sub optimally treated.
ABiC is a comprehensive MIGS procedure that accesses, catheterises and viscodilates the trabecular meshwork, Schlemm’s canal, and importantly, the distal outflow system, beginning with the collector channels.
According to Ellex, ABiC with iTrack is the only MIGS that comprehensively addresses all aspects of potential outflow resistance. In doing so, it removes the guesswork inherent in other MIGS procedures to achieve an average reduction in mean IOP of 30 per cent, combined with a 50 per cent reduction in medication burden.
Contact: Ellex Medical (AUS) 08 8104 5200